Matrix protein 1 (27-35)

Matrix protein 1 (27-35) is a synthetic peptide fragment corresponding to amino acids 27 through 35 of the influenza A virus matrix protein 1 (M1). As a well-defined peptide sequence, it serves as a valuable molecular tool for studying viral protein structure, host-pathogen interactions, and immunological recognition mechanisms. The M1 protein plays a pivotal role in viral assembly and morphogenesis, and its peptide fragments are frequently utilized in virological and immunological research to dissect functional domains and epitope-specific responses. The precise sequence of Matrix protein 1 (27-35) makes it particularly relevant for applications in peptide mapping, epitope characterization, and experimental systems exploring influenza virus biology.

Epitope mapping: Researchers frequently employ this peptide fragment to elucidate the specific regions of the influenza M1 protein recognized by antibodies or T cells. By using Matrix protein 1 (27-35) in immunoassays such as ELISA or peptide-MHC binding studies, investigators can identify immunodominant epitopes, advancing the understanding of antigenic determinants important for immune recognition. Such studies are crucial for defining the molecular basis of host immune responses to influenza infection and for informing vaccine design strategies.

T cell activation studies: The 27-35 region of the M1 protein is known to contain epitopes that are presented by major histocompatibility complex (MHC) molecules to cytotoxic T lymphocytes (CTLs). Synthetic versions of this peptide are routinely used in ex vivo stimulation assays to assess T cell responses, measure cytokine production, and evaluate CTL activity in samples from vaccinated or infected individuals. These applications help clarify the cellular immune mechanisms underlying protection against influenza and support the development of immunological assays for research purposes.

Peptide-based assay development: Matrix protein 1 (27-35) serves as a standardized reagent in the development and optimization of peptide-based detection systems. Its defined sequence allows for the calibration and validation of assays designed to quantify peptide-MHC interactions, antibody binding, or protease activity. Such assays are instrumental in high-throughput screening platforms, quality control procedures, and the advancement of analytical technologies in immunology and virology laboratories.

Structural and functional studies: The availability of this M1-derived peptide enables detailed investigations into the structural features and biological functions of the matrix protein. Researchers can use the peptide in biophysical analyses, such as nuclear magnetic resonance (NMR) or circular dichroism (CD) spectroscopy, to probe secondary structure elements and conformational dynamics. These studies provide insights into the role of specific sequence motifs in protein-protein interactions, viral assembly, and the modulation of host cell processes.

Peptide synthesis and modification research: As a model peptide, Matrix protein 1 (27-35) is also utilized in studies aimed at optimizing solid-phase peptide synthesis methodologies and evaluating chemical modification strategies. Its manageable length and biological relevance make it suitable for testing coupling efficiencies, purification protocols, and labeling techniques. Such work contributes to ongoing improvements in peptide chemistry and supports the development of novel tools for biochemical and virological research.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment